Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
108M
-
Number of holders
-
786
-
Total shares
-
73.8M
-
Shares change
-
+1.81M
-
Total reported value, excl. options
-
$36B
-
Value change
-
+$992M
-
Put/Call ratio
-
0.92
-
Number of buys
-
449
-
Number of sells
-
-317
-
Price
-
$488.29
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2020
825 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2020.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 786 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.8M shares
of 108M outstanding shares and own 68.53% of the company stock.
Largest 10 shareholders include FMR LLC (8.46M shares), Capital World Investors (7.13M shares), BlackRock Inc. (6.6M shares), VANGUARD GROUP INC (6.42M shares), STATE STREET CORP (3.62M shares), LOOMIS SAYLES & CO L P (3.49M shares), HARRIS ASSOCIATES L P (2.32M shares), WELLINGTON MANAGEMENT GROUP LLP (2.06M shares), ALLIANCEBERNSTEIN L.P. (1.82M shares), and POLEN CAPITAL MANAGEMENT LLC (1.72M shares).
This table shows the top 786 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.